{"ok":true,"trend":{"id":76521,"platform":"news","region":"global","key":"arwr stock on track to hit over 5-year highs – retail cheers phase 3 breakthrough as arrowhead targets broader fda approval","title":"ARWR Stock On Track To Hit Over 5-Year Highs – Retail Cheers Phase 3 Breakthrough As Arrowhead Targets Broader FDA Approval","url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQNjVfc2MwU2VWamc5bXVqUXBwMUl0ZnVHM09XdXE3NFY4MmtramZyc1VpRmVocDRzd2lyXzhDcEtMTFYtSHhaOWxfNmd5dDRjWlhrYmJfYVJRWFJ6Q0NqNF96T2xEbDJEejRzVkRYUTVIVGZ1REZvb0s3MjFnX2o3MDY0QVJIN2JWZVVOcVhfbmRrbHU3bzBFVGkzUk83MUFCMHJBNU9GazRXdXc2cHlsS1VkeGFEbk1oU0RkZDE2ZlhxeUhPWGxOZk9laVhYNm1Rb1RwXy12WUJjdw?oc=5","first_seen":"2026-09-27T06:51:40.854551Z","last_seen":"2026-09-27T08:10:45.237886Z","last_rank":28,"peak_rank":22,"last_volume":null,"peak_volume":0,"seen_count":2,"score":25.27,"category_hint":"retail","section":"business","category":"retail","summary":"Arrowhead Pharmaceuticals shares are on track to reach their highest level in more than five years after positive Phase 3 trial results, with retail investors celebrating the biotech's momentum. The company is reportedly aiming for a broader FDA approval than initially expected, fueling optimism about the commercial potential of its drug pipeline and driving renewed interest in the stock.","why":"Retail investors are reacting to the Phase 3 breakthrough and prospects of a wider FDA approval pushing the stock to multi-year highs.","tone":"positive","entities":["Arrowhead Pharmaceuticals","FDA"],"summarized_at":"2026-09-27T06:53:50.650501Z","meta":{"via":"scan","lang":"en","term":"retail","source":"Stocktwits","generic":0.04,"published":"Sat, 26 Sep 2026 20:49:18 GMT"},"nw":0.46,"promo":0.06,"kind":"news_event","importance":1.27,"hidden":false,"hide_reason":null,"judged_at":"2026-09-27T06:51:41.941272Z","title_en":"Arrowhead Pharmaceuticals Stock Nears Five-Year High on Phase 3 Win","section_name":"Business","category_name":"Retail","timeline":[{"captured_at":"2026-09-27T06:51:40.854551Z","rank":22,"volume":null},{"captured_at":"2026-09-27T08:10:45.237886Z","rank":28,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQNjVfc2MwU2VWamc5bXVqUXBwMUl0ZnVHM09XdXE3NFY4MmtramZyc1VpRmVocDRzd2lyXzhDcEtMTFYtSHhaOWxfNmd5dDRjWlhrYmJfYVJRWFJ6Q0NqNF96T2xEbDJEejRzVkRYUTVIVGZ1REZvb0s3MjFnX2o3MDY0QVJIN2JWZVVOcVhfbmRrbHU3bzBFVGkzUk83MUFCMHJBNU9GazRXdXc2cHlsS1VkeGFEbk1oU0RkZDE2ZlhxeUhPWGxOZk9laVhYNm1Rb1RwXy12WUJjdw?oc=5","author":"Stocktwits","title":"ARWR Stock On Track To Hit Over 5-Year Highs – Retail Cheers Phase 3 Breakthrough As Arrowhead Targets Broader FDA Approval","snippet":null,"posted_at":"2026-09-26T20:49:18Z","likes":null}],"elsewhere":[],"window":"7d"}}